[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558376":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":28,"responsibleParty":45,"collaborators":47,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":10,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":71,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Barts & The London NHS Trust","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Medical treatment group",null,"Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) starting a new advanced medical therapy (e.g. biologic or small molecule)",{"label":13,"type":10,"description":14,"interventionNames":10},"Surgical treatment group","Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) undergoing an IBD-related surgery",[16],{"name":17,"affiliation":5,"role":18},"Shameer Mehta, MD","PRINCIPAL_INVESTIGATOR",[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Sarah Faloon, MBChB","CONTACT","07713444631","sarah.faloon@nhs.net",{"name":17,"role":22,"phone":26,"phoneExt":10,"email":27},"020 3594 3500","shameer.mehta@nhs.net",[29],{"facility":30,"status":31,"city":32,"state":10,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Barts Health NHS Trust","RECRUITING","London","N15 4GL","United Kingdom","UK",{"type":37,"coordinates":38},"Point",[39,40],-0.12574,51.50853,{"lat":40,"lon":39},[43],{"name":44,"role":22,"phone":23,"phoneExt":10,"email":24},"Sarah C Faloon",{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[48],{"name":49,"class":6},"King's College London","100558376","nutrition-and-clinical-outcomes-in-ibd-100558376",false,"NCT06550310","Nutrition and Clinical Outcomes in IBD","Nutrition and Body Composition and Association With Clinical Outcomes in Inflammatory Bowel Disease","NUTRICO-IBD","Inclusion Criteria:\n\n* Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) starting a new advanced medical therapy\n* Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) undergoing an IBD-related surgery\n* Age \\>16\n* Patients able and willing to provide written informed consent\n\nExclusion Criteria:\n\n* Patients below the age of 16\n* Patients who cannot provide informed consent\n* Patients with a cardiac pacemaker or internal defibrillator\n* Patients with active cancer and other disorders associated with severe cachexia","ALL","16 Years",{"count":61,"type":62},300,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to demonstrate that nutritional status and body composition have an impact on clinical outcomes in inflammatory bowel disease (IBD).\n\nThe main objectives are:\n\n1. To compare the detection rates of undernutrition between a range of nutritional screening tools, physiological measures and assessment tools amongst patients with different IBD phenotypes\n2. To correlate nutritional status, nutritional biomarkers and body composition with clinical outcomes in patients with IBD treated with advanced medical therapy or surgery\n3. To determine a potential relationship between radiological muscle mass measurements and clinical outcomes in patients with IBD treated with advanced medical therapy or surgery\n\nParticipants will undergo an assessment at pre-treatment baseline and then again at their scheduled follow-up. This is a non-interventional study and participants will not be required to have any invasive tests or hospital visits beyond that of standard clinical care.",[66,67,68,69,70],"Inflammatory Bowel Diseases","Crohn Disease","Ulcerative Colitis","Malnutrition","Sarcopenia",[72,73,74,75,76,70,77,78],"Body composition","Nutritional status","Nutritional markers","Nutritional screening tools","Nutritional assessment","Radiological muscle mass","Inflammatory bowel disease","2026-02-17",{"date":81,"type":82},"2026-02-19","ACTUAL",{"date":84,"type":82},"2024-10-24",{"date":86,"type":62},"2028-12",{"name":5,"class":6},1]